drugset / Trial / NCT00211458
Treatment of Age-Related Macular Degeneration With Anecortave Acetate
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control classic neovascularization following failure of treatment with photodynamic therapy using Visudyne.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 15 mg | — |